Dr Agarwal's Hea

  • Market Cap: Small Cap
  • Industry: Hospital
  • ISIN: INE943P01029
  • NSEID: AGARWALEYE
  • BSEID: 544350
INR
480.50
1.2 (0.25%)
BSENSE

May 25

BSE+NSE Vol: 59.61 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
564.11
529.86
498.69
487.42
460.22
430.72
416.57
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
564.11
529.86
498.69
487.42
460.22
430.72
416.57
Raw Material Cost
0.24
0.22
0.19
0.21
0.29
0.39
0.27
Purchase of Finished goods
57.79
50.33
45.07
49.21
44.18
40.68
44.64
(Increase) / Decrease In Stocks
-5.75
-3.88
0.94
-1.78
-0.62
-5.27
-0.43
Employee Cost
103.79
105.36
99.12
95.52
87.14
83.87
81.16
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
144.48
150.05
132.25
132.32
123.50
122.73
113.15
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
102.09
83.68
84.98
84.08
74.74
73.51
70.81
Total Expenditure (Excl Depreciation)
402.64
385.76
362.55
359.56
329.23
315.91
309.60
Operating Profit (PBDIT) excl Other Income
161.47
144.10
136.14
127.86
130.99
114.81
106.97
Other Income
12.58
10.54
7.93
13.39
15.43
12.71
11.88
Operating Profit (PBDIT)
174.05
154.64
144.07
141.25
146.42
127.52
118.85
Interest
22.08
21.13
22.55
24.70
25.01
28.35
28.40
Exceptional Items
1.33
0.00
0.00
0.00
-2.50
0.00
0.00
Gross Profit (PBDT)
153.30
133.51
121.52
116.55
118.91
99.17
90.45
Depreciation
76.68
68.75
67.86
62.95
60.39
58.18
57.18
Profit Before Tax
76.62
64.76
53.66
53.60
58.52
40.99
33.27
Tax
26.66
21.13
17.17
15.54
15.97
12.75
11.93
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
49.96
43.63
36.49
38.06
42.55
28.24
21.34
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
49.96
43.63
36.49
38.06
42.55
28.24
21.34
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
10.25
9.89
6.80
8.01
9.98
5.90
4.76
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
39.71
33.74
29.69
30.05
32.57
22.34
16.58
Equity Capital
31.68
31.65
31.62
31.62
31.59
30.84
30.76
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
1.25
1.07
0.94
0.95
1.03
0.72
0.54
Diluted Earnings per share
1.24
1.06
0.93
0.95
1.03
0.72
0.45
Operating Profit Margin (Excl OI)
28.62%
27.2%
27.3%
26.23%
28.46%
26.66%
25.68%
Gross Profit Margin
27.18%
25.2%
24.37%
23.91%
25.84%
23.02%
21.71%
PAT Margin
8.86%
8.23%
7.32%
7.81%
9.25%
6.56%
5.12%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is 6.46% vs 6.25% in Dec 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is 17.69% vs 13.64% in Dec 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is 12.05% vs 5.85% in Dec 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is 4.50% vs -6.30% in Dec 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

Compare Quarterly Results Of Dr Agarwal's Hea With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
564.11
1,074.60
-510.49
-47.51%
Other Operating Income
0.00
0.00
0.00
Total Operating income
564.11
1,074.60
-510.49
-47.51%
Raw Material Cost
0.24
0.00
0.24
Purchase of Finished goods
57.79
235.40
-177.61
-75.45%
(Increase) / Decrease In Stocks
-5.75
-2.60
-3.15
-121.15%
Employee Cost
103.79
179.90
-76.11
-42.31%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
144.48
0.00
144.48
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
102.09
455.40
-353.31
-77.58%
Total Expenditure (Excl Depreciation)
402.64
868.10
-465.46
-53.62%
Operating Profit (PBDIT) excl Other Income
161.47
206.50
-45.03
-21.81%
Other Income
12.58
9.70
2.88
29.69%
Operating Profit (PBDIT)
174.05
216.20
-42.15
-19.50%
Interest
22.08
68.10
-46.02
-67.58%
Exceptional Items
1.33
-10.90
12.23
112.20%
Gross Profit (PBDT)
153.30
137.20
16.10
11.73%
Depreciation
76.68
85.00
-8.32
-9.79%
Profit Before Tax
76.62
54.80
21.82
39.82%
Tax
26.66
21.70
4.96
22.86%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
49.96
30.50
19.46
63.80%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
49.96
30.50
19.46
63.80%
Share in Profit of Associates
0.00
2.60
-2.60
-100.00%
Minority Interest
10.25
-9.40
19.65
209.04%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
39.71
42.50
-2.79
-6.56%
Equity Capital
31.68
80.00
-48.32
-60.40%
Face Value
1.00
2.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
1.25
1.06
0.19
17.92%
Diluted Earnings per share
1.24
1.06
0.18
16.98%
Operating Profit Margin (Excl OI)
28.62%
19.22%
0.00
9.40%
Gross Profit Margin
27.18%
12.77%
0.00
14.41%
PAT Margin
8.86%
3.08%
0.00
5.78%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 564.11 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is 6.46% vs 6.25% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 22.57% vs 31.92% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 39.71 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is 17.69% vs 13.64% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 21.92% vs -15.95% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 161.47 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is 12.05% vs 5.85% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 23.27% vs 21.22% in Mar 2025

Quarterly - Interest
Interest 22.08 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is 4.50% vs -6.30% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -11.72% vs -8.69% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 28.62%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025